Comparative Effectiveness of Dalerpen vs. Branded and Other Generic Tadalafil: The “Shift Study”
<b>Background:</b> Phosphodiesterase type 5 inhibitors (PDE5i), particularly tadalafil and sildenafil, are the first-line therapies for erectile dysfunction (ED). After the patent expiration of branded tadalafil in 2017, generic formulations became available. Despite equivalent efficacy,...
| Published in: | Uro |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-4397/5/3/14 |
